Suicidality and risk of suicide - Definition, drug safety concerns, and a necessary target for drug development: A consensus statement

Journal of Clinical Psychiatry

Volumn 71, Issue 8, 2010, Pages

  Meyer, Roger E ^a   Salzman, Carl ^b   Youngstrom, Eric A ^c   Clayton, Paula J ^d   Goodwin, Frederick K ^a,e   Mann, J John ^k   Alphs, Larry D ^f   Broich, Karl ^g   Goodman, Wayne K ^h   Greden, John F ⁱ   Meltzer, Herbert Y ^j   Normand, Sharon Lise T ^b   Posner, Kelly ^k   Shaffer, David ^k   Oquendo, Maria A ^k   Stanley, Barbara ^k   Trivedi, Madhukar H ^l   Turecki, Gustavo ^m   Beasley Jr , Charles M ⁿ   Beautrais, Annette L ^o,p   Bridge, Jeffrey A ^q   Brown, Gregory K ^r   Revicki, Dennis A ^s   Ryan, Neal D ^t   Sheehan, David V ^u   more..

^a Best Practice Project Management Inc   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d American Foundation for Suicide Prevention   (United States)

^e GEORGE WASHINGTON UNIVERSITY   (United States)

^f Ortho McNeil Pharmaceutical Incorporated   (United States)

^g FEDERAL INSTITUTE FOR DRUGS AND MEDICAL DEVICES   (Germany)

^h MOUNT SINAI SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF MICHIGAN   (United States)

^j VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^k NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^l UNIVERSITY OF TEXAS AT DALLAS   (United States)

^m MCGILL UNIVERSITY   (Canada)

ⁿ ELI LILLY AND COMPANY   (United States)

^o YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^p UNIVERSITY OF OTAGO   (New Zealand)

^q NATIONWIDE CHILDREN S HOSPITAL   (United States)

^r UNIVERSITY OF PENNSYLVANIA   (United States)

^s UNITED BIOSOURCE CORPORATION   (United States)

^t UNIVERSITY OF PITTSBURGH   (United States)

^u UNIVERSITY OF SOUTH FLORIDA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; MOOD STABILIZER; NEUROLEPTIC AGENT; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ABUSE; AGE; BIPOLAR DISORDER; CLINICAL RESEARCH; CLINICAL TRIAL; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; DEPRESSION; DRUG DEPENDENCE; DRUG EFFICACY; DRUG SAFETY; DRUG SYNTHESIS; ETHNICITY; FAMILY HISTORY; HEREDITY; HUMAN; MAJOR DEPRESSION; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; PSYCHOMETRY; SCHIZOPHRENIA; SEX DIFFERENCE; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE FACTORS; ANTIDEPRESSIVE AGENTS; CHILD; CLINICAL TRIALS AS TOPIC; CONSENSUS DEVELOPMENT CONFERENCES AS TOPIC; DEPRESSIVE DISORDER, MAJOR; DRUG DISCOVERY; DRUG TOXICITY; HUMANS; MENTAL DISORDERS; META-ANALYSIS AS TOPIC; PSYCHOMETRICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SUICIDE; SUICIDE, ATTEMPTED; TERMINOLOGY AS TOPIC; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 77956008522     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.10cs06070blu     Document Type: Conference Paper

References (195)

1. Committee on Pathophysiology and Prevention of Adolescent and Adult Suicide and Board on Neuroscience and Behavioral Health. Goldsmith SK, Pellmar TC, Kleinman AM, et al, eds. Reducing Suicide: A National Imperative. Washington, DC: National Academies Press, 2002.
2. Fergusson D, Doucette S, Glass KC, et al. Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials. BMJ. 2005;330(7488):396.
3. Christman DS, Faubion MD. Suicide attempt following initiation of topiramate. Am J Psychiatry. 2007;164(4):682-683.
4. Hammad TA, Laughren T, Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry. 2006;63(3):332-339.doi: 10.101/archpsyc.63.3.32 PubMed (Pubitemid 43345358)
5. Kuehn BM. FDA warns of adverse events linked to smoking cessation drug and antiepileptics. JAMA. 2008;299(10):1121-1122.
6. Kalinin VV. Suicidality and antiepileptic drugs: is there a link? Drug Saf. 2007;30(2):123-142.
7. Sørensen HT, Mellemkjaer L, Olsen JH. Risk of suicide in users of beta-adrenoceptor blockers, calcium channel blockers and angiotensin converting enzyme inhibitors. Br J Clin Pharmacol. 2001;52(3):313-318.
8. Stone M, Laughren T, Jones ML, et al. Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration. BMJ. 2009;339(aug11 2):b2880.
9. Katz LY. Concerns about health care warnings and their impact on prescribing behaviour. CMAJ. 2008;179(5):405-406.
10. Gibbons RD, Brown CH, Hur K, et al. Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents. Am J Psychiatry. 2007;164(9):1356-1363.
11. United States Department of Health & Human Services Food and Drug Administration. FDA Advisory: Suicidality and Antiepileptic Drugs. http://www.fda.gov/cder/drug/Infopage/antiepileptics/default.htm.2008
12. Gibbons RD, Hur K, Brown CH, et al. Relationship between antiepileptic drugs and suicide attempts in patients with bipolar disorder. Arch Gen Psychiatry. 2009;66(12):1354-1360.
13. Fergusson DM, Woodward LJ, Horwood LJ. Risk factors and life processes associated with the onset of suicidal behaviour during adolescence and early adulthood. Psychol Med. 2000;30(1):23-39.
14. Gibbons RD, Hur K, Bhaumik DK, et al. The relationship between antidepressant prescription rates and rate of early adolescent suicide. Am J Psychiatry. 2006;163(11):1898-1904.doi:10.176/api.ajp.163.1.1898 PubMed (Pubitemid 44807781)
15. Olfson M, Shaffer D, Marcus SC, et al. Relationship between antidepressant medication treatment and suicide in adolescents. Arch Gen Psychiatry. 2003;60(10):978-982.
16. Søndergård L, Kvist K, Andersen PK, et al. Do antidepressants precipitate youth suicide?: a nationwide pharmacoepidemiological study. Eur Child Adolesc Psychiatry. 2006;15(4):232-240.
17. Simon GE. How can we know whether antidepressants increase suicide risk? Am J Psychiatry. 2006;163(11):1861-1863.
18. Valuck RJ, Libby AM, Orton HD, et al. Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs. Am J Psychiatry. 2007;164(8):1198-1205.
19. Posner K, Oquendo MA, Gould M, et al. Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. Am J Psychiatry. 2007;164(7):1035-1043.
20. American Psychiatric Association. Practice Guideline for the Assessment and Treatment of Patients With Suicidal Behaviors. Am J Psychiatry. 2003;160(suppl 11):1-60.
21. Beck AT, Brown GK, Steer RA. Psychometric characteristics of the Scale for Suicide Ideation with psychiatric outpatients. Behav Res Ther. 1997;35(11):1039-1046.doi:10.1016/S05-7967(97)073-9 PubMed (Pubitemid 27522426)
22. Brown GK, Beck AT, Steer RA, et al. Risk factors for suicide in psychiatric outpatients: a 20-year prospective study. J Consult Clin Psychol. 2000;68(3):371-377.
23. Joiner TE Jr, Steer RA, Brown GK, et al. Worst-point suicidal plans: a dimension of suicidality predictive of past suicide attempts and eventual death by suicide. Behav Res Ther. 2003;41(12):1469-1480.
24. Brown G. A Review of Suicide Assessment Measures for Intervention Research with Adults and Older Adults. Philadelphia, PA: University of Pennsylvania; 2002.
25. Goldston D. Assessment of Suicidal Behaviors and Risk Among Children and Adolescents. Technical report submitted to NIMH under contract 263-MD-909995. 2000.
26. Nock MK, Wedig MM, Janis IB, et al. Self-injurious thoughts and behaviors. In: Hunsley J, Mash EJ, eds. A Guide to Assessments That Work. London, United Kingdom: Oxford University Press; 2008:158-178.
27. Range LM, Knott EC. Twenty suicide assessment instruments: evaluation and recommendations. Death Stud. 1997;21(1):25-58.
28. Winters NC, Myers K, Proud L. Ten-year review of rating scales, III: scales assessing suicidality, cognitive style, and self-esteem. J Am Acad Child Adolesc Psychiatry. 2002;41(10):1150-1181.
29. Bruce ML, Ten Have TR, Reynolds CF 3rd, et al. Reducing suicidal ideation and depressive symptoms in depressed older primary care patients: a randomized controlled trial. JAMA. 2004;291(9):1081-1091.
30. Messick S. Validity of psychological assessment: validation of inferences from persons' responses and performances as scientific inquiry into score meaning. Am Psychol. 1995;50(9):741-749.
31. Harkavy Friedman JM, Asnis G. Assessment of suicidal behavior: a new instrument. Psychiatr Ann. 1989;19:382-387.
32. Coric V, Stock EG, Pultz J, et al. Sheehan Suicidality Tracking Scale (Sheehan-STS): preliminary results from a multicenter clinical trial in generalized anxiety disorder. Psychiatry (Edgmont). 2009;6(1):26-31.
33. Lindenmayer JP, Czobor P, Alphs L, et al. InterSePT Study Group. The InterSePT Scale for Suicidal Thinking: reliability and validity. Schizophr Res. 2003;63(1-2):161-170.
34. Alphs LD, Lindenmayer JP. The InterSePT Scale for Suicidal Thinking- Plus (ISST-Plus): a modified instrument for the comprehensive assessment of suicidality in clinical trials of patients with schizophrenia or schizoaffective disorder. ISCTM 2009 Autumn Conference; October 5-6, 2009; San Diego, CA.
35. Cotton CR, Peters DK, Range LM. Psychometric properties of the Suicidal Behaviors Questionnaire. Death Stud. 1995;19(4):391-397.
36. Beck AT, Kovacs M, Weissman A. Assessment of suicidal intention: the Scale for Suicide Ideation. J Consult Clin Psychol. 1979;47(2):343-352.doi:10. 1037/02-06X.47.2.343 PubMed (Pubitemid 9157284)
37. Beck AT, Steer RA. Manual for the Beck Scale for Suicidal Ideation. San Antonio, TX: Psychological Corporation; 1991.
38. Nock MK, Holmberg EB, Photos VI, et al. Self-Injurious Thoughts and Behaviors Interview: development, reliability, and validity in an adolescent sample. Psychol Assess. 2007;19(3):309-317.
39. Posner K. Suicidality Across Drug Indications: Columbia Suicidal Adverse Event Identification and FDA Safety Concerns: The Issues and the Answers, From Outcomes to Feasibility. Presented at the Center for Drug Evaluation and Research (CDER), US Food and Drug Administration; 2008; Silver Spring, MD.
40. Brent DA, Emslie GJ, Clarke GN, et al. Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-esistant depression in adolescents (TORDIA) study. Am J Psychiatry. 2009;166(4):418-426.
41. Brown GK, Currier G, Stanley B. Suicide Attempt Registry Pilot Project. Presented at the National Institute of Mental Health annual meeting of the Developing Center for Intervention and Prevention of Suicide; September 2008; Canandaigua, NY.
42. Alphs LD, Anand R, Islam MZ, et al. The International Suicide Prevention Trial (interSePT): rationale and design of a trial comparing the relative ability of clozapine and olanzapine to reduce suicidal behavior in schizophrenia and schizoaffective patients. Schizophr Bull. 2004; 30(3):577-586.
43. Straus SE, Richardson WS, Glasziou P, et al. Evidence-Based Medicine: How to Practice and Teach EBM. 3rd ed. New York, NY: Churchill Livingstone; 2005.
44. Guyatt GH, Rennie D, eds. Users' Guides to the Medical Literature. Chicago, IL: AMA Press; 2002.
45. Linehan MM, Comtois KA, Brown MZ, et al. Suicide Attempt Self-Injury Interview (SASII): development, reliability, and validity of a scale to assess suicide attempts and intentional self-injury. Psychol Assess. 2006;18(3):303-312.
46. Miller IW, Norman WH, Bishop SB, et al. The Modified Scale for Suicidal Ideation: reliability and validity. J Consult Clin Psychol. 1986;54(5): 724-725.
47. Pinninti N, Steer RA, Rissmiller DJ, et al. Use of the Beck Scale for Suicide Ideation with psychiatric inpatients diagnosed with schizophrenia, schizoaffective, or bipolar disorders. Behav Res Ther. 2002;40(9): 1071-1079.
48. Patton GC, Coffey C, Sawyer SM, et al. Global patterns of mortality in young people: a systematic analysis of population health data. Lancet. 2009;374(9693):881-892.
49. Tortolero SR, Roberts RE. Differences in nonfatal suicide behaviors among Mexican and European American middle school children. Suicide Life Threat Behav. 2001;31(2):214-223.
50. Azocar F, Areán P, Miranda J, et al. Differential item functioning in a Spanish translation of the Beck Depression Inventory. J Clin Psychol. 2001;57(3):355-365.
51. Breslau J, Javaras KN, Blacker D, et al. Differential item functioning between ethnic groups in the epidemiological assessment of depression. J Nerv Ment Dis. 2008;196(4):297-306.doi:10.1097/NMD.0b013e31816a490e PubMed (Pubitemid 351548730)
52. Oquendo MA, Baca-Garcia E, Graver R, et al. Spanish adaptation of the Reasons for Living Inventory. Hisp J Behav Sci. 2000;22(3):369-381.
53. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(suppl 20):22-33, quiz 34-57.
54. Ayer DW, Jayathilake K, Meltzer HY. The InterSePT suicide scale for prediction of imminent suicidal behaviors. Psychiatry Res. 2008;161(1): 87-96.
55. Beck AT, Brown GK, Steer RA, et al. Suicide ideation at its worst point: a predictor of eventual suicide in psychiatric outpatients. Suicide Life Threat Behav. 1999;29(1):1-9.
56. Rush B. Medical Inquiries and Observations, Upon the Diseases of the Mind. Philadelphia, PA: Kimber & Richardson; 1812.
57. Mayer-Gross W, Slater E, Roth M. Clinical Psychiatry. London, United Kingdom: Bailliere, Tindall, and Cassell; 1960:231.
58. Noyes AP, Haydon EM. A Textbook of Psychiatry. New York, NY: Macmillian; 1940.
59. Teicher MH, Glod C, Cole JO. Emergence of intense suicidal preoccupation during fluoxetine treatment. Am J Psychiatry. 1990;147(2):207-210.
60. Beasley CM Jr, Dornseif BE, Bosomworth JC, et al. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. BMJ. 1991;303(6804):685-692.
61. Khan A, Khan S, Kolts R, et al. Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports. Am J Psychiatry. 2003;160(4):790-792.doi:10.176/api.ajp.160.4.790 PubMed (Pubitemid 41079617)
62. US Food and Drug Administration. Relationship between psychotropic drugs and pediatric suicidality. http://www.fda.gov/ohrms/dockets/ ac/04/briefing/2004-4065b1-10-TAB08-Hammads-Review.pdf. Accessed January 10, 2005.
63. Bridge JA, Iyengar S, Salary CB, et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA. 2007;297(15):1683-1696.
64. Mosholder AD, Willy M. Suicidal adverse events in pediatric randomized, controlled clinical trials of antidepressant drugs are associated with active drug treatment: a meta-analysis. J Child Adolesc Psychopharmacol. 2006;16(1-2):25-32.
65. Vitiello B, Silva SG, Rohde P, et al. Suicidal events in the Treatment for Adolescents With Depression Study (TADS). J Clin Psychiatry. 2009;70(5):741-747.
66. Simon GE, Savarino J, Operskalski B, et al. Suicide risk during antidepressant treatment. Am J Psychiatry. 2006;163(1):41-47.
67. Baldessarini RJ, Pompili M, Tondo L. Suicidal risk in antidepressant drug trials. Arch Gen Psychiatry. 2006;63(3):246-248.doi:10.101/archpsyc.63.3.246 PubMed (Pubitemid 43345347)
68. Kraemer HC, Kazdin AE, Offord DR, et al. Coming to terms with the terms of risk. Arch Gen Psychiatry. 1997;54(4):337-343.
69. Olfson M, Marcus SC, Shaffer D. Antidepressant drug therapy and suicide in severely depressed children and adults: a case-control study. Arch Gen Psychiatry. 2006;63(8):865-872.
70. Gray D, Achilles J, Keller T, et al. Utah youth suicide study, phase I: government agency contact before death. J Am Acad Child Adolesc Psychiatry. 2002;41(4):427-434.
71. Leon AC, Marzuk PM, Tardiff K, et al. Paroxetine, other antidepressants, and youth suicide in New York City: 1993 through 1998. J Clin Psychiatry. 2004;65(7):915-918.
72. Carlsten A, Waern M, Ekedahl A, et al. Antidepressant medication and suicide in Sweden. Pharmacoepidemiol Drug Saf. 2001;10(6):525-530.
73. Gibbons RD, Hur K, Bhaumik DK, et al. The relationship between antidepressant medication use and rate of suicide. Arch Gen Psychiatry. 2005;62(2):165-172.
74. Hall WD, Mant A, Mitchell PB, et al. Association between antidepressant prescribing and suicide in Australia, 1991-2000: trend analysis. BMJ. 2003;326(7397):1008.
75. Isacsson G. Suicide prevention - a medical breakthrough? Acta Psychiatr Scand. 2000;102(2):113-117.
76. Isacsson G, Bergman U, Rich CL. Epidemiological data suggest antidepressants reduce suicide risk among depressives. J Affect Disord. 1996; 41(1):1-8.
77. Ludwig J, Marcotte DE. Anti-depressants, suicide, and drug regulation. J Policy Anal Manage. 2005;24(2):249-272.
78. Morgan OW, Griffiths C, Majeed A. Association between mortality from suicide in England and antidepressant prescribing: an ecological study. BMC Public Health. 2004;4(1):63.
79. Ohberg A, Vuori E, Klaukka T, et al. Antidepressants and suicide mortality. J Affect Disord. 1998;50(2-3):225-233.
80. Liu KY. Suicide rates in the world: 1950-2004. Suicide Life Threat Behav. 2009;39(2):204-213.
81. Safer DJ, Zito JM. Do antidepressants reduce suicide rates? Public Health. 2007;121(4):274-277.
82. Anderson RN. Deaths: Leading Causes for 2000. National Vital Statistics Reports 50(16). Hyattsville, MD: National Center for Health Statistics; 2002.
83. Gould MS, Greenberg T, Velting DM, et al. Youth suicide risk and preventive interventions: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry. 2003;42(4):386-405. PubMed (Pubitemid 39625074)
84. Centers for Disease Control and Prevention (CDC). Suicide trends among youths and young adults aged 10-24 years-United States, 1990-2004. MMWR Morb Mortal Wkly Rep. 2007;56(35):905-908.
85. Bridge JA, Greenhouse JB, Weldon AH, et al. Suicide trends among youths aged 10 to 19 years in the United States, 1996-2005. JAMA. 2008;300(9):1025- 1026.
86. Nelson JC, Delucchi K, Schneider L. Suicidal thinking and behavior during treatment with sertraline in late-life depression. Am J Geriatr Psychiatry. 2007;15(7):573-580.
87. Un̈zer J, Tang L, Oishi S, et al. for the IMPACT Investigators. Reducing suicidal ideation in depressed older primary care patients. J Am Geriatr Soc. 2006;54(10):1550-1556.
88. Normand S-L, McNeil BJ. What is evidence? Stat Med. In press.
89. Strom BL. Pharmacoepidemiology. 4th ed. New York, NY: John Wiley; 2005.
90. Rothwell PM. External validity of randomised controlled trials: "to whom do the results of this trial apply?" Lancet. 2005;365(9453):82-93.
91. Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med. 1971;284(15):878-881.
92. Koro CE, Fedder DO, L'Italien GJ, et al. Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study. BMJ. 2002;325(7358):243-245.
93. Greenhouse JB, Kelleher KJ. Thinking outside the (black) box: antidepressants, suicidality, and research synthesis. Pediatrics. 2005;116(1): 231-233.
94. Droitcour J, Silberman G, Chelimsky E. A new form of meta-analysis for combining results from randomized clinical trials and medical-practice databases. Int J Technol Assess Health Care. 1993;9(3):440-449.
95. Trivedi MH, Rush AJ, Wisniewski SR, et al. STAR*D Study Team. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006;163(1):28-40.
96. Meltzer HY, Alphs L, Green AI, et al. International Suicide Prevention Trial Study Group. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry. 2003;60(1):82-91.
97. Walker AM, Lanza LL, Arellano F, et al. Mortality in current and former users of clozapine. Epidemiology. 1997;8(6):671-677.
98. Tiihonen J, Lönnqvist J, Wahlbeck K, et al. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet. 2009;374(9690):620-627.
99. Goodwin FK, Fireman B, Simon GE, et al. Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA. 2003;290(11): 1467-1473.doi:10.101/jama.290.1.1467 PubMed (Pubitemid 37430401)
100. Smith EG, Søndergård L, Lopez AG, et al. Association between consistent purchase of anticonvulsants or lithium and suicide risk: a longitudinal cohort study from Denmark, 1995-2001. J Affect Disord. 2009;117(3):162-167.
101. Oquendo MA, Galfalvy HC, Tin A, et al. Interventions for suicidal behavior in bipolar disorder. Neuropsychopharmacology. 2007;43:S142-S143.
102. Chaudron LH, Remington P. Age and gender differences in suicide trends, Wisconsin and the United States, 1980-1994. WMJ. 1999; 98(6):35-38.
103. Vyrostek SB, Annest JL, Ryan GW. Surveillance for fatal and nonfatal injuries - United States, 2001. MMWR Surveill Summ. 2004;53(7):1-57.
104. Boxer PA, Burnett C, Swanson N. Suicide and occupation: a review of the literature. J Occup Environ Med. 1995;37(4):442-452.
105. Frank E, Biola H, Burnett CA. Mortality rates and causes among US physicians. Am J Prev Med. 2000;19(3):155-159.
106. Kliewer EV, Ward RH. Convergence of immigrant suicide rates to those in the destination country. Am J Epidemiol. 1988;127(3):640-653.
107. Olson LM, Wahab S. American Indians and suicide: a neglected area of research. Trauma Violence Abuse. 2006;7(1):19-33.
108. Kposowa AJ. Unemployment and suicide: a cohort analysis of social factors predicting suicide in the US National Longitudinal Mortality Study. Psychol Med. 2001;31(1):127-138.
109. Kaprio J, Koskenvuo M, Rita H. Mortality after bereavement: a prospective study of 95,647 widowed persons. Am J Public Health. 1987;77(3): 283-287.
110. Luoma JB, Pearson JL. Suicide and marital status in the United States, 1991-1996: is widowhood a risk factor? Am J Public Health. 2002; 92(9):1518-1522.
111. Smith JC, Mercy JA, Conn JM. Marital status and the risk of suicide. Am J Public Health. 1988;78(1):78-80.
112. American Association of Suicidology. Youth Suicide Fact Sheet. http://www.suicidology.org/c/document-library/get-file?folderId=232&name= DLFE-24.pdf. January 28, 2008. Accessed June 2, 2010.
113. Brener ND, Billy JOG, Grady WR. Assessment of factors affecting the validity of self-reported health-risk behavior among adolescents: evidence from the scientific literature. J Adolesc Health. 2003;33(6): 436-457.
114. Brener ND, Eaton DK, Kann L, et al. The association of survey setting and mode with self-reported health risk behaviors among high school students. Public Opin Q. 2006;70(3):354-374.
115. Shafii M, Steltz-Lenarsky J, Derrick AM, et al. Comorbidity of mental disorders in the post-mortem diagnosis of completed suicide in children and adolescents. J Affect Disord. 1988;15(3):227-233.doi:10.1016/0165-0327(8)9020-1 PubMed (Pubitemid 18259389)
116. Brent DA, Baugher M, Bridge J, et al. Age- and sex-related risk factors for adolescent suicide. J Am Acad Child Adolesc Psychiatry. 1999;38(12): 1497-1505.
117. Shaffer D, Gould MS, Fisher P, et al. Psychiatric diagnosis in child and adolescent suicide. Arch Gen Psychiatry. 1996;53(4):339-348.
118. Harris EC, Barraclough B. Suicide as an outcome for mental disorders: a meta-analysis. Br J Psychiatry. 1997;170(3):205-228.doi:10.192/bjp.170.3.205 PubMed (Pubitemid 27117683)
119. Arsenault-Lapierre G, Kim C, Turecki G. Psychiatric diagnoses in 3,275 suicides: a meta-analysis. BMC Psychiatry. 2004;4(1):37.
120. Cavanagh JT, Carson AJ, Sharpe M, et al. Psychological autopsy studies of suicide: a systematic review. Psychol Med. 2003;33(3):395-405.
121. Brent DA, Perper JA, Moritz G, et al. Psychiatric risk factors for adolescent suicide: a case-control study. J Am Acad Child Adolesc Psychiatry. 1993;32(3):521-529.doi:10.1097/04583-193050-06 PubMed (Pubitemid 23149027)
122. Fowler RC, Rich CL, Young D. San Diego Suicide Study, II: substance abuse in young cases. Arch Gen Psychiatry. 1986;43(10):962-965. PubMed (Pubitemid 17168416)
123. Lesage AD, Boyer R, Grunberg F, et al. Suicide and mental disorders: a case-control study of young men. Am J Psychiatry. 1994;151(7): 1063-1068.
124. Rich CL, Fowler RC, Fogarty LA, et al. San Diego Suicide Study. III: relationships between diagnoses and stressors. Arch Gen Psychiatry. 1988;45(6):589-592.
125. Foley DL, Goldston DB, Costello EJ, et al. Proximal psychiatric risk factors for suicidality in youth: the Great Smoky Mountains Study. Arch Gen Psychiatry. 2006;63(9):1017-1024.
126. Brezo J, Barker ED, Paris J, et al. Childhood trajectories of anxiousness and disruptiveness as predictors of suicide attempts. Arch Pediatr Adolesc Med. 2008;162(11):1015-1021.
127. Cukrowicz KC, Duberstein PR, Vannoy SD, et al. Course of suicide ideation and predictors of change in depressed older adults. J Affect Disord. 2009;113(1-2):30-36.
128. Conwell Y, Thompson C. Suicidal behavior in elders. Psychiatr Clin North Am. 2008;31(2):333-356.
129. Vannoy SD, Duberstein P, Cukrowicz K, et al. The relationship between suicide ideation and late-life depression. Am J Geriatr Psychiatry. 2007; 15(12):1024-1033.
130. Aizenberg D, Olmer A, Barak Y. Suicide attempts amongst elderly bipolar patients. J Affect Disord. 2006;91(1):91-94.
131. Angst J, Preisig M. Outcome of a clinical cohort of unipolar, bipolar and schizoaffective patients: results of a prospective study from 1959 to 1985. Schweiz Arch Neurol Psychiatr. 1995;146(1):17-23.
132. Beautrais AL. A case control study of suicide and attempted suicide in older adults. Suicide Life Threat Behav. 2002;32(1):1-9.doi:10.1521/suli.32.1.1. 2184 PubMed (Pubitemid 34252886)
133. Henriksson MM, Marttunen MJ, Isometsä ET, et al. Mental disorders in elderly suicide. Int Psychogeriatr. 1995;7(2):275-286.
134. Conwell Y, Rotenberg M, Caine ED. Completed suicide at age 50 and over. J Am Geriatr Soc. 1990;38(6):640-644.
135. Cattell H. Suicidal behavior. In: Copeland JRM, Abou-Saleh MT, Blazer DG, eds. Principles and Practice of Geriatric Psychiatry. New York, NY: John Wiley and Sons; 1994:607-614.
136. Heisel MJ, Links PS, Conn D, et al. Narcissistic personality and vulnerability to late-life suicidality. Am J Geriatr Psychiatry. 2007;15(9): 734-741.
137. Pfaff JJ, Almeida OP, Witte TK, et al. Relationship between quantity and frequency of alcohol use and indices of suicidal behavior in an elderly Australian sample. Suicide Life Threat Behav. 2007;37(6):616-626.
138. Rubenowitz E, Waern M, Wilhelmson K, et al. Life events and psychosocial factors in elderly suicides - a case-control study. Psychol Med. 2001;31(7):1193-1202.
139. Schneider KL, Shenassa E. Correlates of suicide ideation in a population- based sample of cancer patients. J Psychosoc Oncol. 2008;26(2): 49-62.
140. Erlangsen A, Zarit SH, Conwell Y. Hospital-diagnosed dementia and suicide: a longitudinal study using prospective, nationwide register data. Am J Geriatr Psychiatry. 2008;16(3):220-228.
141. Dombrovski AY, Butters MA, Reynolds CF 3rd, et al. Cognitive performance in suicidal depressed elderly: preliminary report. Am J Geriatr Psychiatry. 2008;16(2):109-115.
142. Angst F, Stassen HH, Clayton PJ, et al. Mortality of patients with mood disorders: follow-up over 34-38 years. J Affect Disord. 2002;68 (2-3):167-181.doi:10.1016/S0165-0327(01)037-9 PubMed (Pubitemid 34628324)
143. Angst J, Angst F, Gerber-Werder R, et al. Suicide in 406 mood-disorder patients with and without long-term medication: a 40 to 44 years' follow-up. Arch Suicide Res. 2005;9(3):279-300.
144. Guze SB, Robins E. Suicide and primary affective disorders. Br J Psychiatry. 1970;117(539):437-438.
145. Hagnell O, Lanke J, Rorsman B. Suicide and depression in the male part of the Lundby study: changes over time during a 25-year observation period. Neuropsychobiology. 1982;8(4):182-187.
146. Tondo L, Isacsson G, Baldessarini RJ. Suicidal behaviour in bipolar disorder: risk and prevention. CNS Drugs. 2003;17(7):491-511.doi:10.2165/023210- 20317070-03 PubMed (Pubitemid 36693704)
147. Tondo L, Baldessarini RJ. Suicidal risk in bipolar disorder. Clin Neuropsychiatry. 2005;2:55-65.
148. Baldessarini RJ, Pompili M, Tondo L. Bipolar disorder. In: Simon RI, Hales RE, eds. Textbook of Suicide Assessment and Management. Washington, DC: American Psychiatric Press; 2006:277-299.
149. Baldessarini RJ, Tondo L. Pharmacology of suicide prevention. In: Tatarelli R, Pompili M, Girardi P, eds. Suicide in Psychiatric Disorders. New York, NY: Nova Publishers; 2007:193-213.
150. Tondo L, Lepri B, Baldessarini RJ. Suicidal risks among 2,826 Sardinian major affective disorder patients. Acta Psychiatr Scand. 2007;116(6): 419-428.doi:10.1/j.160-047.207.0106.x PubMed (Pubitemid 350086143)
151. Tondo L, Lepri B, Baldessarini RJ. Suicidal status during antidepressant treatment in 789 Sardinian patients with major affective disorder. Acta Psychiatr Scand. 2008;118(2):106-115.
152. Dumais A, Lesage AD, Alda M, et al. Risk factors for suicide completion in major depression: a case-control study of impulsive and aggressive behaviors in men. Am J Psychiatry. 2005;162(11):2116-2124.
153. Turecki G. Dissecting the suicide phenotype: the role of impulsive-aggressive behaviours. J Psychiatry Neurosci. 2005;30(6):398-408. PubMed (Pubitemid 41812486)
154. McGirr A, Renaud J, Séguin M, et al. An examination of DSM-IV depressive symptoms and risk for suicide completion in major depressive disorder: a psychological autopsy study. J Affect Disord. 2007;97(1-3):203-209.
155. Fawcett J, Scheftner WA, Fogg L, et al. Time-related predictors of suicide in major affective disorder. Am J Psychiatry. 1990;147(9): 1189-1194.
156. Busch KA, Fawcett J, Jacobs DG. Clinical correlates of inpatient suicide. J Clin Psychiatry. 2003;64(1):14-19.
157. Coryell W, Schlesser M. The dexamethasone suppression test and suicide prediction. Am J Psychiatry. 2001;158(5):748-753.doi:10.176/api.ajp.158.5.748 PubMed (Pubitemid 32429843)
158. Coryell W, Young EA. Clinical predictors of suicide in primary major depressive disorder. J Clin Psychiatry. 2005;66(4):412-417.
159. McGirr A, Renaud J, Séguin M, et al. Course of major depressive disorder and suicide outcome: a psychological autopsy study. J Clin Psychiatry. 2008;69(6):966-970.
160. Henriksson MM, Aro HM, Marttunen MJ, et al. Mental disorders and comorbidity in suicide. Am J Psychiatry. 1993;150(6):935-940.
161. Murphy GE, Wetzel RD, Robins E, et al. Multiple risk factors predict suicide in alcoholism. Arch Gen Psychiatry. 1992;49(6):459-463.
162. Brent DA, Perper JA, Allman CJ. Alcohol, firearms, and suicide among youth: temporal trends in Allegheny County, Pennsylvania, 1960 to 1983. JAMA. 1987;257(24):3369-3372.
163. Kim C, Lesage A, Seguin M, et al. Patterns of co-morbidity in male suicide completers. Psychol Med. 2003;33(7):1299-1309.
164. Isometsä ET, Lönnqvist JK. Suicide attempts preceding completed suicide. Br J Psychiatry. 1998;173(6):531-535.
165. McGuffin P, Marusic A, Farmer A. What can psychiatric genetics offer suicidology? Crisis. 2001;22(2):61-65.
166. Roy A, Nielsen D, Rylander G, et al. Genetics of suicide in depression. J Clin Psychiatry. 1999;60(suppl 2):12-17, discussion 18-20, 113-116.
167. Brent DA, Bridge J, Johnson BA, et al. Suicidal behavior runs in families: a controlled family study of adolescent suicide victims. Arch Gen Psychiatry. 1996;53(12):1145-1152. PubMed (Pubitemid 26422067)
168. Kim CD, Seguin M, Therrien N, et al. Familial aggregation of suicidal behavior: a family study of male suicide completers from the general population. Am J Psychiatry. 2005;162(5):1017-1019.
169. Egeland JA, Sussex JN. Suicide and family loading for affective disorders. JAMA. 1985;254(7):915-918.
170. Melhem NM, Brent DA, Ziegler M, et al. Familial pathways to early-onset suicidal behavior: familial and individual antecedents of suicidal behavior. Am J Psychiatry. 2007;164(9):1364-1370.
171. McGirr A, Alda M, Séguin M, et al. Familial aggregation of suicide explained by cluster B traits: a three-group family study of suicide controlling for major depressive disorder. Am J Psychiatry. 2009;166(10):1124- 1134.
172. Trémeau F, Staner L, Duval F, et al. Suicide attempts and family history of suicide in three psychiatric populations. Suicide Life Threat Behav. 2005;35(6):702-713.
173. Doyle JP, Frank E, Saltzman LE, et al. Domestic violence and sexual abuse in women physicians: associated medical, psychiatric, and professional difficulties. J Womens Health Gend Based Med. 1999;8(7):955-965. PubMed (Pubitemid 29501940)
174. Simon TR, Anderso M, Thompson MP, et al. Assault victimization and suicidal ideation or behavior within a national sample of US adults. Suicide Life Threat Behav. 2002;32(1):42-50.
175. Plunkett A, O'Toole B, Swanston H, et al. Suicide risk following child sexual abuse. Ambul Pediatr. 2001;1(5):262-266.
176. Brezo J, Paris J, Tremblay R, et al. Identifying correlates of suicide attempts in suicidal ideators: a population-based study. Psychol Med. 2007;37(11):1551-1562.doi:10.1017/S032917070803 PubMed (Pubitemid 47606843)
177. McGill Group for Suicide Studies. Suicidal Behaviors: Genetic Association Studies Database. http://gmes.mcgill.ca/SBGAS-home. html. Accessed October 25, 2009.
178. Brezo J, Bureau A, Mérette C, et al. Differences and similarities in the serotonergic diathesis for suicide attempts and mood disorders: a 22-year longitudinal gene-environment study [published online ahead of print April 21, 2009]. Mol Psychiatry.
179. Currier D, Mann JJ. Stress, genes and the biology of suicidal behavior. Psychiatr Clin North Am. 2008;31(2):247-269.
180. Galfalvy H, Huang YY, Oquendo MA, et al. Increased risk of suicide attempt in mood disorders and TPH1 genotype. J Affect Disord. 2009;115(3):331-338.
181. Lopez de Lara C, Dumais A, Rouleau G, et al. STin2 variant and family history of suicide as significant predictors of suicide completion in major depression. Biol Psychiatry. 2006;59(2):114-120.
182. Lopez de Lara C, Brezo J, Rouleau G, et al. Effect of tryptophan hydroxylase-2 gene variants on suicide risk in major depression. Biol Psychiatry. 2007;62(1):72-80.
183. Zubenko GS, Maher BS, Hughes HB 3rd, et al. Genome-wide linkage survey for genetic loci that affect the risk of suicide attempts in families with recurrent, early-onset, major depression. Am J Med Genet B Neuropsychiatr Genet. 2004;129B(1):47-54.
184. Laje G, Paddock S, Manji H, et al. Genetic markers of suicidal ideation emerging during citalopram treatment of major depression. Am J Psychiatry. 2007;164(10):1530-1538.
185. Perlis RH, Purcell S, Fava M, et al. Association between treatmentemergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study. Arch Gen Psychiatry. 2007;64(6):689-697.
186. Perroud N, Aitchison KJ, Uher R, et al. Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP project. Neuropsychopharmacology. 2009;34(12):2517-2528.
187. Jokinen J, Carlborg A, Mårtensson B, et al. DST non-suppression predicts suicide after attempted suicide. Psychiatry Res. 2007;150(3): 297-303.doi:10.1016/j.psychres.206.12.01 PubMed (Pubitemid 46466966)
188. Jokinen J, Nordström P. HPA axis hyperactivity and attempted suicide in young adult mood disorder inpatients. J Affect Disord. 2009;116(1-2): 117-120.
189. Appleton KM, Rogers PJ, Ness AR. Is there a role for n-3 long-chain polyunsaturated fatty acids in the regulation of mood and behaviour? a review of the evidence to date from epidemiological studies, clinical studies and intervention trials. Nutr Res Rev. 2008;21(1):13-41.
190. Sublette ME, Milak MS, Hibbeln JR, et al. Plasma polyunsaturated fatty acids and regional cerebral glucose metabolism in major depression. Prostaglandins Leukot Essent Fatty Acids. 2009;80(1):57-64.
191. Lalovic A, Levy E, Canetti L, et al. Fatty acid composition in postmortem brains of people who completed suicide. J Psychiatry Neurosci. 2007a;32(5):363-370.
192. Lalovic A, Levy E, Luheshi G, et al. Cholesterol content in brains of suicide completers. Int J Neuropsychopharmacol. 2007b;10(2):159-166.doi:10.1017/ S146145706063 PubMed (Pubitemid 46270991)
193. Oquendo MA, Stanley B, Ellis SP, et al. Protection of human subjects in intervention research for suicidal behavior. Am J Psychiatry. 2004;161(9):1558-1563.
194. Stanley B, Brown G, Brent DA, et al. Cognitive-behavioral therapy for suicide prevention (CBT-SP): treatment model, feasibility, and acceptability. J Am Acad Child Adolesc Psychiatry. 2009;48(10):1005-1013.
195. Reynolds WM. Professional Manual for the Suicidal Ideation Questionnaire. Lutz, FL: Psychological Assessment Resources; 1987.